The purpose of this study is to evaluate the safety, tolerability, and efficacy of an investigational islet cell infusion in individuals aged 18 to 65 with type 1 diabetes with severe low blood sugar (hypoglycemia) and impaired hypoglycemic awareness. The goal of this infusion is to provide replacement cells for the ones that have been lost or do not work properly in people with diabetes. For more information, please respond to this ad and the study team will reach out to you.
Sponsor
Vertex Pharmaceuticals Incorporated (Vertex)
Principle Investigator
Trevor Reichman
Researchers
Honey Lad
erin winter
Co-investigators
Bruce Perkins
Recruiting time left
Days
:
Hours
:
Minutes
:
Seconds
Contribute
Participating in research not only gives you access to innovative treatments, but also allows you to contribute to the discovery of new therapies.